Clopidogrel and vascular disease prevention
نویسندگان
چکیده
منابع مشابه
Is clopidogrel superior to aspirin in secondary prevention of vascular disease?
The cornerstone in clinical evidence of the relative efficacy of thienopyridines (clopidogrel, ticlopidine) versus aspirin in the secondary prevention of vascular disease is the Clopidogrel versus Aspirin in Patients at Risk of Ischaemic Events trial. This trial showed a modest benefit in the reduction of vascular events by clopidogrel. The results differed according to qualifying disorder: myo...
متن کاملVascular disease, hypertension, and prevention.
M M s w t d e i m c s e 1 r i he Vascular-Hypertension-Prevention (VHP) track inludes data on vascular biology, hypertension, lipids, horones, thrombosis, and cardiovascular epidemiology and rovides insight into the prevention and treatment of oronary heart disease (CHD) and cerebrovascular and eripheral artery disease. On behalf of my colleagues on the cientific Program Committee, I am privile...
متن کاملExtracardiac vascular disease and effectiveness of sustained clopidogrel treatment.
OBJECTIVE To assess the effectiveness of long term treatment with clopidogrel of patients with extracardiac vascular disease (ECVD) (a history of either peripheral arterial disease or cerebrovascular disease). DESIGN Subgroup analysis of a prospective randomised clinical trial. SETTING The CREDO (clopidogrel for the reduction of events during observation) trial was a randomised, double blin...
متن کاملEffectiveness of clopidogrel and MR-dipyridanmole in the prevention of occlusive vascular events
I t is widely accepted that atherothrombosis is the most important cause of occlusive vascular events. The clinical manifestations of atherothrombosis include transient ischaemic attack (TIA), ischaemic stroke, unstable angina, myocardial infarction (MI) and intermittent claudication. The importance of long-term secondary prevention in patients at high risk of recurrent vascular events is clear...
متن کاملPrimary prevention of atherosclerotic vascular disease.
Reprinted with permission from CME April 2006 Vol. 24 No. 4 A therosclerosis is one of the most common causes of death and dis ability throughout the world. Cardiovascular diseases are expected to be the main cause of death globally within the next 15 years owing to a rapidly increasing prevalence in developing countries and Eastern Europe and the rising incidence of obesity and diabetes in the...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Current Medical Research and Opinion
سال: 2004
ISSN: 0300-7995,1473-4877
DOI: 10.1185/030079904x10656